
Global Molecular Scissors Technology Market
Description
MARKET SCOPE:
The global Molecular Scissors Technology market is projected to grow significantly, registering a CAGR of 8.6% during the forecast period (2024 – 2032).
The technique of molecular scissoring involves utilizing restriction enzymes, commonly known as molecular scissors, to cut DNA at specific recognition sequences called restriction sites. Each of the two strands of DNA is incised, and the cleaved DNA can be subsequently transferred to vectors. These vectors have the capability to infect host cells by exploiting the host cell machinery for reproduction. Molecular scissors, thus, play a crucial role in molecular biology as versatile tools for gene editing, mapping, and sequencing. Additionally, molecular scissoring technology has applications in the research focused on preventing and treating diseases in plants, animals, and humans.
MARKET OVERVIEW:
Driver: The increase in adoption of molecular scissoring technology to gain structural information about the genetic material is driving the market growth.
DNA mapping is a process that utilizes molecular scissors, also known as restriction enzymes, to gather detailed structural information about genetic material. The primary goal of DNA mapping is to determine the order of restriction enzyme sites within the genome, providing a comprehensive understanding of the genetic composition of an organism.
The process involves cutting DNA at specific recognition sequences, known as restriction sites, using restriction enzymes. These enzymes act as molecular scissors, cleaving the DNA at precise locations. Once the DNA is cut, the resulting fragments can be separated and analyzed, revealing the arrangement of the restriction sites along the DNA molecule. The rise in the number of studies conducted with the purpose of DNA mapping in various countries has contributed significantly to the growth of the molecular scissors market. These studies involve the exploration and identification of specific genes, regulatory elements, and other crucial components within the genome. Researchers use DNA mapping to create a detailed genetic map, aiding in the understanding of gene function, genetic variations, and the relationships between different genes. The information obtained through DNA mapping is invaluable for various applications in molecular biology, including gene sequencing, genetic engineering, and studying the genetic basis of diseases. Additionally, advancements in DNA mapping technologies, such as next-generation sequencing methods, have further fueled the expansion of the molecular scissors market.
As more countries engage in genomic research and personalized medicine initiatives, the demand for molecular scissors for DNA mapping purposes is expected to increase. The market growth is propelled by the expanding scope of genomics research and the continuous pursuit of unraveling the intricacies of the genetic code for both scientific and medical applications.
Opportunities: Technological advancement and increasing R&D activities are expected to pave the way for market growth in the upcoming years.
Numerous research and development (R&D) activities are concentrated in the field of molecular biology, specifically in areas such as molecular cloning, restriction landmark genomic scanning (RLGS), gene sequencing, and serial analysis of gene expression (SAGE). These activities play a crucial role in advancing the understanding of genetics and gene function, and they contribute significantly to the growth of the molecular scissors technology market. The growth of the molecular scissors technology market is closely tied to the expansion of R&D activities in these crucial molecular biology fields. As researchers continue to explore and apply these techniques in various scientific and medical domains, the demand for molecular scissors and related technologies is expected to increase, driving innovation and market growth.
COVID IMPACT:
COVID-19 is an infectious disease that originated in the Hubei province of Wuhan, China, in late December. The highly transmissible disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted among humans. Since the initial outbreak in December 2019, the disease has spread to nearly 213 countries worldwide, leading the World Health Organization to declare it a public health emergency on March 11, 2020. Pharmaceutical and biotech companies, along with governments globally, are collaborating to address the COVID-19 outbreak, supporting vaccine development and planning for challenges in the medicine supply chain. Currently, there are approximately 115 vaccine candidates and 155 molecules in the research and development pipeline. Additionally, commonly used drugs like hydroxychloroquine have experienced a substantial surge in demand for managing COVID-19. The heightened demand for these drugs presents significant opportunities for manufacturers of COVID-19 management drugs, particularly as several developed countries are grappling with shortages. Consequently, the pharmaceutical and biotechnology industries are anticipated to experience substantial growth in the future due to the demand for COVID-19 vaccine and treatment drugs. This is expected to exert a notable influence on the molecular scissoring technology market.
SEGMENTATION ANALYSIS:
The Cas9 segment is anticipated to grow significantly during the forecast period.
Molecular cloning is the process of generating identical copies or clones of a particular DNA fragment, often encompassing a gene or a regulatory element. In the context of the Molecular Scissors Technology Market, molecular scissors, also known as restriction enzymes, play a crucial role in the molecular cloning process. These enzymes are utilized to precisely cleave DNA at specific recognition sequences, enabling researchers to incorporate or ""clone"" the targeted DNA fragment into a vector, which serves as a carrier DNA molecule. This technology holds fundamental significance across diverse applications, including the production of recombinant proteins, gene therapy, and the exploration of gene function.
Restriction Landmark Genomic Scanning (RLGS) is a method employed for the analysis of genomic DNA fragments based on their patterns of digestion by restriction enzymes. This technique facilitates the identification and mapping of genomic landmarks or specific regions of interest. Regarding its impact on the Molecular Scissors Technology Market, molecular scissors stand as pivotal tools in RLGS. These enzymes are employed to enzymatically digest genomic DNA at predetermined sites. Subsequently, the resulting fragments undergo analysis to construct a comprehensive map of the genome. This process aids in identifying genetic variations, structural abnormalities, or specific genes associated with diseases. RLGS holds particular significance in the realms of genomic research and diagnostics, contributing valuable insights to the understanding of genetic compositions and their implications in various disorders.
The Cell Line Engineering segment is anticipated to grow significantly during the forecast period.
Cell line engineering involves the manipulation or modification of the genetic composition of a cell line for various objectives, commonly utilizing molecular scissors technologies like CRISPR-Cas9 or other genome editing tools. The primary objective is to introduce specific genetic alterations to attain desired traits or functions in the cells. This technology finds diverse applications across research, biotechnology, and medicine. Researchers employ molecular scissors to inactivate or ""knock out"" specific genes within a cell line, facilitating the examination of individual gene functions and their impact on cellular processes. Additionally, molecular scissors can be utilized to integrate new genetic material into a targeted location in the genome, allowing for the introduction of novel genes or modifications, serving both therapeutic and research purposes.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
The robust biotechnology and pharmaceutical sector in the region foster research and development in CRISPR technology, particularly for drug discovery and therapeutics. Additionally, the region benefits from growing government funding, research grants, a well-established healthcare infrastructure, and a favorable regulatory environment, all of which contribute to the widespread adoption of CRISPR in clinical trials and therapeutic applications.
COMPETITIVE ANALYSIS
The global Molecular Scissors Technology market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
Merck
Thermo Fisher Scientific, Inc.
Precision BioSciences
Caribou Biosciences, Inc.
Cellectis
Editas Medicine
Recombinetics
Intellia Therapeutics, Inc.
Cibus, Inc.
SCOPE OF THE REPORT
By Type
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Molecular Scissors Technology market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Molecular Scissors Technology submarket will be the main driver of the overall market from 2024 to 2032.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.
The global Molecular Scissors Technology market is projected to grow significantly, registering a CAGR of 8.6% during the forecast period (2024 – 2032).
The technique of molecular scissoring involves utilizing restriction enzymes, commonly known as molecular scissors, to cut DNA at specific recognition sequences called restriction sites. Each of the two strands of DNA is incised, and the cleaved DNA can be subsequently transferred to vectors. These vectors have the capability to infect host cells by exploiting the host cell machinery for reproduction. Molecular scissors, thus, play a crucial role in molecular biology as versatile tools for gene editing, mapping, and sequencing. Additionally, molecular scissoring technology has applications in the research focused on preventing and treating diseases in plants, animals, and humans.
MARKET OVERVIEW:
Driver: The increase in adoption of molecular scissoring technology to gain structural information about the genetic material is driving the market growth.
DNA mapping is a process that utilizes molecular scissors, also known as restriction enzymes, to gather detailed structural information about genetic material. The primary goal of DNA mapping is to determine the order of restriction enzyme sites within the genome, providing a comprehensive understanding of the genetic composition of an organism.
The process involves cutting DNA at specific recognition sequences, known as restriction sites, using restriction enzymes. These enzymes act as molecular scissors, cleaving the DNA at precise locations. Once the DNA is cut, the resulting fragments can be separated and analyzed, revealing the arrangement of the restriction sites along the DNA molecule. The rise in the number of studies conducted with the purpose of DNA mapping in various countries has contributed significantly to the growth of the molecular scissors market. These studies involve the exploration and identification of specific genes, regulatory elements, and other crucial components within the genome. Researchers use DNA mapping to create a detailed genetic map, aiding in the understanding of gene function, genetic variations, and the relationships between different genes. The information obtained through DNA mapping is invaluable for various applications in molecular biology, including gene sequencing, genetic engineering, and studying the genetic basis of diseases. Additionally, advancements in DNA mapping technologies, such as next-generation sequencing methods, have further fueled the expansion of the molecular scissors market.
As more countries engage in genomic research and personalized medicine initiatives, the demand for molecular scissors for DNA mapping purposes is expected to increase. The market growth is propelled by the expanding scope of genomics research and the continuous pursuit of unraveling the intricacies of the genetic code for both scientific and medical applications.
Opportunities: Technological advancement and increasing R&D activities are expected to pave the way for market growth in the upcoming years.
Numerous research and development (R&D) activities are concentrated in the field of molecular biology, specifically in areas such as molecular cloning, restriction landmark genomic scanning (RLGS), gene sequencing, and serial analysis of gene expression (SAGE). These activities play a crucial role in advancing the understanding of genetics and gene function, and they contribute significantly to the growth of the molecular scissors technology market. The growth of the molecular scissors technology market is closely tied to the expansion of R&D activities in these crucial molecular biology fields. As researchers continue to explore and apply these techniques in various scientific and medical domains, the demand for molecular scissors and related technologies is expected to increase, driving innovation and market growth.
COVID IMPACT:
COVID-19 is an infectious disease that originated in the Hubei province of Wuhan, China, in late December. The highly transmissible disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted among humans. Since the initial outbreak in December 2019, the disease has spread to nearly 213 countries worldwide, leading the World Health Organization to declare it a public health emergency on March 11, 2020. Pharmaceutical and biotech companies, along with governments globally, are collaborating to address the COVID-19 outbreak, supporting vaccine development and planning for challenges in the medicine supply chain. Currently, there are approximately 115 vaccine candidates and 155 molecules in the research and development pipeline. Additionally, commonly used drugs like hydroxychloroquine have experienced a substantial surge in demand for managing COVID-19. The heightened demand for these drugs presents significant opportunities for manufacturers of COVID-19 management drugs, particularly as several developed countries are grappling with shortages. Consequently, the pharmaceutical and biotechnology industries are anticipated to experience substantial growth in the future due to the demand for COVID-19 vaccine and treatment drugs. This is expected to exert a notable influence on the molecular scissoring technology market.
SEGMENTATION ANALYSIS:
The Cas9 segment is anticipated to grow significantly during the forecast period.
Molecular cloning is the process of generating identical copies or clones of a particular DNA fragment, often encompassing a gene or a regulatory element. In the context of the Molecular Scissors Technology Market, molecular scissors, also known as restriction enzymes, play a crucial role in the molecular cloning process. These enzymes are utilized to precisely cleave DNA at specific recognition sequences, enabling researchers to incorporate or ""clone"" the targeted DNA fragment into a vector, which serves as a carrier DNA molecule. This technology holds fundamental significance across diverse applications, including the production of recombinant proteins, gene therapy, and the exploration of gene function.
Restriction Landmark Genomic Scanning (RLGS) is a method employed for the analysis of genomic DNA fragments based on their patterns of digestion by restriction enzymes. This technique facilitates the identification and mapping of genomic landmarks or specific regions of interest. Regarding its impact on the Molecular Scissors Technology Market, molecular scissors stand as pivotal tools in RLGS. These enzymes are employed to enzymatically digest genomic DNA at predetermined sites. Subsequently, the resulting fragments undergo analysis to construct a comprehensive map of the genome. This process aids in identifying genetic variations, structural abnormalities, or specific genes associated with diseases. RLGS holds particular significance in the realms of genomic research and diagnostics, contributing valuable insights to the understanding of genetic compositions and their implications in various disorders.
The Cell Line Engineering segment is anticipated to grow significantly during the forecast period.
Cell line engineering involves the manipulation or modification of the genetic composition of a cell line for various objectives, commonly utilizing molecular scissors technologies like CRISPR-Cas9 or other genome editing tools. The primary objective is to introduce specific genetic alterations to attain desired traits or functions in the cells. This technology finds diverse applications across research, biotechnology, and medicine. Researchers employ molecular scissors to inactivate or ""knock out"" specific genes within a cell line, facilitating the examination of individual gene functions and their impact on cellular processes. Additionally, molecular scissors can be utilized to integrate new genetic material into a targeted location in the genome, allowing for the introduction of novel genes or modifications, serving both therapeutic and research purposes.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
The robust biotechnology and pharmaceutical sector in the region foster research and development in CRISPR technology, particularly for drug discovery and therapeutics. Additionally, the region benefits from growing government funding, research grants, a well-established healthcare infrastructure, and a favorable regulatory environment, all of which contribute to the widespread adoption of CRISPR in clinical trials and therapeutic applications.
COMPETITIVE ANALYSIS
The global Molecular Scissors Technology market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
Merck
- In May 2020, Merck has secured approval for two of its CRISPR-Cas9-assisted genome editing patents in the United States. This strategic move has enabled the company to broaden its customer base.
Thermo Fisher Scientific, Inc.
Precision BioSciences
Caribou Biosciences, Inc.
Cellectis
Editas Medicine
Recombinetics
Intellia Therapeutics, Inc.
Cibus, Inc.
SCOPE OF THE REPORT
By Type
- Cas9
- TALENs and MegaTALs
- ZFN
- Others
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Others
- North America (the United States & Canada)
- Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)
- Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
- Rest of the World (the Middle East & Africa, and Latin America)
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Molecular Scissors Technology market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Molecular Scissors Technology submarket will be the main driver of the overall market from 2024 to 2032.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.
Table of Contents
170 Pages
- 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Regional Analysis
- 1.3. Segment Analysis
- 2. Overview And Scope
- 2.1. Market Vision
- 2.1.1. Market Definition
- 2.2. Market Segmentation
- 3. Global Molecular Scissors Technology Market Overview By Region: 2019 Vs 2023 Vs 2032
- 3.1. Global Molecular Scissors Technology Market Size By Regions (2019-2023) (Usd Million)
- 3.1.1. North America Molecular Scissors Technology Market Size By Country (2019-2023) (Usd Million)
- 3.1.2. Europe Molecular Scissors Technology Market Size By Country (2019-2023) (Usd Million)
- 3.1.3. Asia Pacific America Molecular Scissors Technology Market Size By Country (2019-2023) (Usd Million)
- 3.1.4. Rest Of The World Molecular Scissors Technology Market Size By Country (2019-2023) (Usd Million)
- 3.2. Global Molecular Scissors Technology Market Size By Regions (2024-2032) (Usd Million)
- 3.2.1. North America Molecular Scissors Technology Market Size By Country (2024-2032) (Usd Million)
- 3.2.2. Europe Molecular Scissors Technology Market Size By Country (2024-2032) (Usd Million)
- 3.2.3. Asia Pacific Molecular Scissors Technology Market Size By Country (2024-2032) (Usd Million)
- 3.2.4. Rest Of The World Molecular Scissors Technology Market Size By Country (2024-2032) (Usd Million)
- 4. Global Molecular Scissors Technology Market Dynamics
- 4.1. Market Overview
- 4.1.1. Market Drivers
- 4.1.2. Market Restraints/ Challenges Analysis
- 4.1.3. Market Opportunities
- 4.2. Pestle Analysis
- 4.3. Porter’s Five Forces Model
- 4.3.1. Bargaining Power Of Suppliers
- 4.3.2. Bargaining Power Of Buyers
- 4.3.3. The Threat Of New Entrants
- 4.3.4. Threat Of Substitutes
- 4.3.5. Intensity Of Rivalry
- 4.4. Value Chain Analysis/Supply Chain Analysis
- 4.5. Covid-19 Impact Analysis On Global Molecular Scissors Technology Market
- ** In – Depth Qualitative Analysis Will Be Provided In The Final Report Subject To Market
- 5. Global Molecular Scissors Technology Market, By Type
- 5.1. Overview
- 5.2. Global Molecular Scissors Technology Market Size By Type
- 5.3. Key Findings For Molecular Scissors Technology Market - By Type
- 5.3.1. Cas9
- 5.3.2. Talens And Megatals
- 5.3.3. Zfn
- 5.3.4. Others
- 6. Global Molecular Scissors Technology Market, By Application
- 6.1. Overview
- 6.2. Key Findings For Molecular Scissors Technology Market - By Application
- 6.2.1. Cell Line Engineering
- 6.2.2. Animal Genetic Engineering
- 6.2.3. Plant Genetic Engineering
- 6.2.4. Others
- 7. Global Molecular Scissors Technology Market, By Region
- 7.1. Overview
- 7.2. Key Findings For Molecular Scissors Technology Market- By Region
- 7.3. Global Molecular Scissors Technology Market, By Type
- 7.4. Global Molecular Scissors Technology Market, By Application
- 8. Global Molecular Scissors Technology Market- North America
- 8.1. Overview
- 8.2. North America Molecular Scissors Technology Market Size (2019 - 2032) (Usd Million)
- 8.3. North America Molecular Scissors Technology Market, By Type
- 8.4. North America Molecular Scissors Technology Market, By Application
- 8.5. North America Molecular Scissors Technology Market Size By Countries
- 8.5.1. United States
- 8.5.2. Canada
- 9. Global Molecular Scissors Technology Market- Europe
- 9.1. Overview
- 9.2. Europe Molecular Scissors Technology Market Size (2019 - 2032) (Usd Million)
- 9.3. Europe Molecular Scissors Technology Market, By Type
- 9.4. Europe Molecular Scissors Technology Market, By Application
- 9.5. Europe Molecular Scissors Technology Market Size By Countries
- 9.5.1. Germany
- 9.5.2. Uk
- 9.5.3. France
- 9.5.4. Spain
- 9.5.5. Italy
- 9.5.6. Rest Of Europe
- 10. Global Molecular Scissors Technology Market - Asia Pacific
- 10.1. Overview
- 10.2. Asia Pacific Molecular Scissors Technology Market Size (2019 - 2032) (Usd Million)
- 10.3. Asia Pacific Molecular Scissors Technology Market, By Type
- 10.4. Asia Pacific Molecular Scissors Technology Market, By Application
- 10.5. Asia Pacific Molecular Scissors Technology Market Size By Countries
- 10.5.1. China
- 10.5.2. Japan
- 10.5.3. India
- 10.5.4. Rest Of Asia Pacific
- 11. Global Molecular Scissors Technology Market- Rest Of World
- 11.1. Overview
- 11.2. Rest Of World Molecular Scissors Technology Market Size (2019 - 2032) (Usd Million)
- 11.3. Rest Of World Molecular Scissors Technology Market, By Type
- 11.4. Rest Of World Molecular Scissors Technology Market, By Application
- 11.5. Rest Of World Molecular Scissors Technology Market Size By Regions
- 11.5.1. Middle East & Africa
- 11.5.2. Latin America
- 12. Global Molecular Scissors Technology Market- Competitive Landscape
- 12.1. Key Strategies Adopted By The Leading Players
- 12.2. Recent Developments
- 12.2.1. Investments & Expansions
- 12.2.2. New End-user Launches
- 12.2.3. Mergers & Acquisitions
- 12.2.4. Agreements, Joint Ventures, And Partnerships
- 13. Global Molecular Scissors Technology Market- Company Profiles
- 13.1. Merck
- 13.1.1. Company Overview
- 13.1.2. Financial Overview
- 13.1.3. Product Offered
- 13.1.4. Key Developments
- 13.2. Sangamo Therapeutics
- 13.3. Thermo Fisher Scientific, Inc.
- 13.4. Precision Biosciences
- 13.5. Caribou Biosciences, Inc.
- 13.6. Cellectis
- 13.7. Editas Medicine
- 13.8. Recombinetics
- 13.9. Intellia Therapeutics, Inc.
- 13.10. Cibus, Inc.
- 14. Our Research Methodology
- 14.1. Data Triangulation
- 14.2. Data Sources
- 14.2.1. Secondary Sources
- 14.2.2. Primary Sources
- 14.3. Assumptions/ Limitations For The Study
- 14.4. Research & Forecasting Methodology
- 15. Appendix
- 15.1. Disclaimer
- 15.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.